WORLD PEPTIDEFOUNDATION
← Master Registry

Published peptide research references

Iseganan

Governed registry record

3 approved source records with original-source links. Source verification confirms the reference and its connection to this record; it does not certify every scientific conclusion or establish safety or efficacy.

Approved source records

  1. A randomized double-blind trial of iseganan in prevention of ventilator-associated pneumonia.

    DOI: 10.1164/rccm.200504-656oc

    Source identity and connection checked by Codex (AI).

  2. Antimicrobial peptides (Temporin A and Iseganan IB-367): effect on the cysticerci of Taenia crassiceps.

    DOI: 10.1016/j.molbiopara.2008.12.006

    Source identity and connection checked by Codex (AI).

  3. Iseganan HCl: a novel antimicrobial agent.

    DOI: 10.1517/13543784.11.8.1161

    Source identity and connection checked by Codex (AI).

Legacy research context

Context from the legacy curated dataset. Its counts describe that dataset and are separate from the live approved source records above.

Researchers represented

  • Toney JH
  • Giles FJ
  • Redman R
  • Yazji S
  • Bellm L
  • Kollef M
  • Pittet D
  • Sánchez García M
  • Chastre J
  • Fagon JY
  • Bonten M
  • Hyzy R
  • Fleming TR
  • Fuchs H
  • Mercat A
  • Mañez R
  • Martínez A
  • Eggimann P
  • Daguerre M
  • Luyt CE
  • Prevention of Pneumonia Study (POPS-1) Trial Group
  • Landa A
  • Jiménez L
  • Willms K
  • Jiménez-García LF
  • Lara-Martínez R
  • Robert L
  • Cirioni O
  • Barańska-Rybak W
  • Kamysz W